Literature DB >> 15699229

Effects of n-3 fatty acids from fish on premature ventricular complexes and heart rate in humans.

Anouk Geelen1, Ingeborg A Brouwer, Evert G Schouten, Arie C Maan, Martijn B Katan, Peter L Zock.   

Abstract

BACKGROUND: A large body of evidence suggests that n-3 fatty acids from fish prevent fatal heart disease. They may be an effective and safe alternative to drug treatment for reducing the risk of arrhythmia and sudden cardiac death.
OBJECTIVE: We investigated the effect of n-3 fatty acids on heart rate and premature ventricular complexes (PVCs), a common form of arrhythmia that may trigger arrhythmias that are more life-threatening.
DESIGN: Patients (n=84) with >or=1440 PVCs/24 h in a previous Holter recording were randomly assigned to receive 1.5 g/d of either n-3 fatty acids or placebo. Two 24-h Holter recordings were made at baseline, and 2 were made after an intervention of approximately 14 wk.
RESULTS: Treatment did not significantly affect the number of PVCs. The number decreased in the fish-oil group by 867/24 h more than it decreased in placebo group (95% CI: -3187, 1453). However, the mean 24-h heart rate was significantly affected, decreasing in the fish-oil group by a mean of 2.1 beats/min more than it decreased in the placebo group (95% CI: -3.9, -0.3).
CONCLUSIONS: Supplementation with 1.5 g n-3 fatty acids/d from fish does not substantially suppress the number of PVCs in a patient population with frequent PVCs. However, n-3 fatty acids decreased heart rate by 2.1 beats/min, a significant decrease that predicts a lower risk of sudden death.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699229     DOI: 10.1093/ajcn.81.2.416

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  19 in total

Review 1.  Fish oil in critical illness: mechanisms and clinical applications.

Authors:  Renee D Stapleton; Julie M Martin; Konstantin Mayer
Journal:  Crit Care Clin       Date:  2010-07       Impact factor: 3.598

Review 2.  Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis.

Authors:  David J A Jenkins; Andrea R Josse; Joseph Beyene; Paul Dorian; Michael L Burr; Roxanne LaBelle; Cyril W C Kendall; Stephen C Cunnane
Journal:  CMAJ       Date:  2008-01-15       Impact factor: 8.262

Review 3.  Long-chain n-3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease.

Authors:  Baukje de Roos; Yiannis Mavrommatis; Ingeborg A Brouwer
Journal:  Br J Pharmacol       Date:  2009-05-05       Impact factor: 8.739

4.  Functional and safety evaluation of transgenic pork rich in omega-3 fatty acids.

Authors:  Maoxue Tang; Lili Qian; Shengwang Jiang; Jian Zhang; Pengkun Song; Yaoxing Chen; Wentao Cui; Kui Li
Journal:  Transgenic Res       Date:  2014-04-04       Impact factor: 2.788

5.  n-3 PUFA esterified to glycerol or as ethyl esters reduce non-fasting plasma triacylglycerol in subjects with hypertriglyceridemia: a randomized trial.

Authors:  Anne Hedengran; Pal B Szecsi; Jørn Dyerberg; William S Harris; Steen Stender
Journal:  Lipids       Date:  2014-11-18       Impact factor: 1.880

6.  Low dietary fish-oil threshold for myocardial membrane n-3 PUFA enrichment independent of n-6 PUFA intake in rats.

Authors:  Emily L Slee; Peter L McLennan; Alice J Owen; Mandy L Theiss
Journal:  J Lipid Res       Date:  2010-03-10       Impact factor: 5.922

Review 7.  Electrophysiological mechanisms of the anti-arrhythmic effects of omega-3 fatty acids.

Authors:  Eric S Richardson; Paul A Iaizzo; Yong-Fu Xiao
Journal:  J Cardiovasc Transl Res       Date:  2010-12-02       Impact factor: 4.132

Review 8.  Extending the cardiovascular benefits of omega-3 Fatty acids.

Authors:  William S Harris
Journal:  Curr Atheroscler Rep       Date:  2005-09       Impact factor: 5.113

9.  Omega-3 fatty acid supplementation for the prevention of arrhythmias.

Authors:  Mina K Chung
Journal:  Curr Treat Options Cardiovasc Med       Date:  2008-09

10.  [European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. CEIPC 2008 Spanish Adaptation].

Authors:  José M A Lobos Bejarano; Miguel Angel Royo-Bordonada; Carlos Brotons; Luís Alvarez-Sala; Pedro Armario; Antonio Maiques; Dídac Mauricio; Susana Sans; Fernando Villar; Angel Lizcano; Antonio Gil-Núñez; Fernando de Alvaro; Pedro Conthe; Emilio Luengo; Alfonso Del Río; Olga Cortés; Ana de Santiago; Miguel A Vargas; Mercedes Martínez; Vicenta Lizarbe
Journal:  Aten Primaria       Date:  2009-07-15       Impact factor: 1.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.